Influenza and Covid-19 Combination Vaccine
Influenza, commonly called the flu, is a highly contagious virus and is one of the leading causes of death in the world and older adults are at a greater risk of serious complications, such as lung and heart diseases. COVID-19 is also highly infectious and annual boosters are recommended to maintain a high level of protection over time.
This research study is being conducted as there is a need for a combination vaccine of Influenza and COVID-19 to ensure there is continuing protection annually when the viruses are in circulation. This type of combination vaccine of Influenza and COVID-19 will make it easier to receive protection against both viruses in one vaccine rather than receiving the vaccines individually in the future.
The study would require you to come to the clinic 5 times over 6 months. Visits will range between 15 mins to 90 minutes each time you come in. Over the course of the study, we will check your medical history, draw blood, and inject the study vaccine. You will also need to complete an app on your phone to record data for 6 days following your vaccinations.
You will be reimbursed for your time and expenses related to the research study.
- Between 50 and 80 years of age
- Must have completed your most recent dose of COVID-19 vaccine 8 weeks or more before this study begins
- Has not tested positive for COVID-19 in the last 8 weeks
- Relatively healthy